We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cogentix Medical (CGNT) Catches Eye: Stock Jumps 7.7%
Read MoreHide Full Article
Cogentix Medical, Inc. (CGNT - Free Report) was a big mover last session, as the company saw its shares rise almost 8% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.57 to $2.60 in the past one-month time frame.
In the last 30 days, the company has seen one upward estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting that more solid trading could be ahead for Cogentix Medical. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Cogentix Medical currently sports a Zacks Rank #1 (Strong Buy), while its Earnings ESP is 0.00%.
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public. Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cogentix Medical (CGNT) Catches Eye: Stock Jumps 7.7%
Cogentix Medical, Inc. (CGNT - Free Report) was a big mover last session, as the company saw its shares rise almost 8% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.57 to $2.60 in the past one-month time frame.
In the last 30 days, the company has seen one upward estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting that more solid trading could be ahead for Cogentix Medical. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Cogentix Medical currently sports a Zacks Rank #1 (Strong Buy), while its Earnings ESP is 0.00%.
COGENTIX MEDICL Price
COGENTIX MEDICL Price | COGENTIX MEDICL Quote
Another well-ranked Medical-Instruments stock is Syneron Medical Ltd. , which sports the same Zacks Rank as Cogentix Medical. You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public. Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades>>